B-Cell Maturation Antigen (BCMA) Targeted Therapies Emerge As a Promising Treatment for Multiple Mye

Ajinkyaaa08 Jun, 2021Health

Precision medicine is based on knowing the effects of certain gene mutations (changes). The goal of precision medicine is to give a treatment that can target a gene mutation, without causing too many side effects. In precision medicine, B-Cell Maturation Antigen (BCMA) is a novel treatment target for multiple myeloma (MM) due to its highly selective expression in malignant plasma cells (PCs).

Recent Profiles

Skin111

Skin111

View Profile

Schroeder Olsen

Schroeder Olsen

View Profile

Awaaz Entertainment

Awaaz Entertainment

View Profile

Pagh Keith

Pagh Keith

View Profile

InstaPro

Instapro

View Profile

Crowder Blalock

Crowder Blalock

View Profile

Sentinel Home Inspections, LLC

Sentinel Home Inspections, Llc

View Profile

Brady Bryan

Brady Bryan

View Profile

Jennings Greenwood

Jennings Greenwood

View Profile

Omar Steen

Omar Steen

View Profile